Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 15.27MNon-Current Liabilities
VS
Market
Sector
Industry
History
$ 4.41Close
$ 2.88 - $ 4.9 52-Week Range
Ticker Information
Ticker
ABUSCompany Name
ARBUTUS BIOPHARMA CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQARBUTUS BIOPHARMA CORP - Non-Current Liabilities Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABUS - LiabilitesNC Historical data
| Date | Non-Current Liabilities |
|---|---|
| 6/30/2025 | $ 15.27M |
| 3/31/2025 | $ 18.42M |
| 12/31/2024 | $ 18.72M |
| 9/30/2024 | $ 14.63M |
| 6/30/2024 | $ 14.99M |
| 3/31/2024 | $ 15.36M |
| 12/31/2023 | $ 15.9M |
| 9/30/2023 | $ 16.98M |
| 6/30/2023 | $ 17.6M |
| 3/31/2023 | $ 22.16M |
Key Performance Insights, Last 5 Years
- ARBUTUS BIOPHARMA CORP's latest trailing twelve months (TTM) LiabilitesNC stands at $ 26.15M.
- Over the past 5 years, ARBUTUS BIOPHARMA CORP's average LiabilitesNC has been $ 22.5M.
- The median LiabilitesNC for ARBUTUS BIOPHARMA CORP during this period was $ 22.99M
- ARBUTUS BIOPHARMA CORP reached its highest LiabilitesNC over the past 5 years at $ 38.62M.
- The lowest LiabilitesNC recorded by ARBUTUS BIOPHARMA CORP in the same timeframe $ 14.63M
ARBUTUS BIOPHARMA CORP's LiabilitesNC vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
LiabilitesNC Benchmarks
Similar metrics to LiabilitesNC:
- Current Liabilities - [Balance Sheet] The current (short-term) portion of [Liabilities] includes obligations that are due to be paid to creditors within one year, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Total Liabilities - [Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.
- Non-Current Debt - [Balance Sheet] The non-current (long-term) portion of [Debt] includes the formal borrowings that are due after the period of one year; reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Current Debt - [Balance Sheet] The current (short-term) portion of [Debt] includes the formal borrowings that are due within a year; reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]
- Free Cash Flow to Debt - [Calculation] The Free Cash Flow to Debt ratio allows investors to judge a company’s financial stability. It represents the fraction of debt that could be repaid within one year if all of the free cash flow would be used to repay debt. It is calculated by dividing Free Cash Flow [FCF] by a company’s [Liabilities].
Definition of Non-Current Liabilities
[Balance Sheet] The non-current (long-term) portion of [Liabilities] includes obligations that are due to be paid to creditors more than year in the future, reported if the company operates a classified balance sheet that segments current and non-current [Liabilities]ABUS - Non-Current Liabilities, Last 5 years
$ 14.63M
Minimum
Sep 30, 2024
$ 38.62M
Maximum
Mar 31, 2022
$ 22.5M
Average
$ 22.99M
Median
LiabilitesNC Benchmark AnalysisMarket
The chart above depicts the distribution of LiabilitesNC for companies in the Total Stock Market. The average LiabilitesNC of the companies is $ 126.18M with a standard deviation of $ 195.54M.
The following table provides additional summary stats:
LiabilitesNC in the Market:
| filtered constituents | 2.54K |
|---|---|
| min | $ 0 |
| max | $ 831.92M |
| average | $ 126.18M |
| median | $ 24.38M |
| std | $ 195.54M |